Two Bear Capital, the venture capital firm investing in disruptors in biotechnology, bioinformatics, healthcare IT, machine learning and AI, and information security, announced the opening of its New York headquarters within the Alexandria Center for Life Science in New York City.
The New York presence is a part of the firm’s strategic growth plans on the East Coast and the location within the Alexandria Center allows for greater collaboration and access to founders and partners with breakthrough ideas. Two Bear Capital’s portfolio company Sanavia Oncology, which has a propriety platform for replicating cancer biology ex-vivo with unprecedented accuracy, is also headquartered at Alexandria.
To lead the New York operations, Two Bear Capital named Mark Adams as a Venture Partner. Adams brings more than 25 years of developing and managing scientific and technical teams to the firm. Prior to joining Two Bear, he served as Chief Operating Officer and Chief Technology Officer of Adaptive Biotechnologies; Managing Director of Healthcare Advanced Analytics with SVB Leerink; and Chief Information Officer of Celmatix and Good Start Genetics. Adams received his PhD in Cell Biology from Baylor College of Medicine and a BA in Biology and Computer Science from Oberlin College.
Two Bear Capital’s New York headquarters are located at 430 East 29th Street, Suite 945, New York, NY 10016.
Founded in 2019 by Mike Goguen, Two Bear Capital is a venture capital firm that focuses on early founder-led companies with disruptive innovations in biotechnology, bioinformatics, healthcare IT, machine learning and AI, and information security. The firm has offices in Menlo Park, San Diego, Boston, and New York, with its home base in Whitefish, Montana.